natgillin/translations-raw huggingface dataset:
micro-organisms of the sewage treatment plant for products used for the disinfection of footwear and animals' hooves.
površinski vodi in usedlinam za proizvode, ki se uporabljajo za: i) razkuževanje prostorov za živali; ii) razkuževanje vozil, ki se uporabljajo za prevoz živali; iii) razkuževanje obutve in kopit živali;
For products that may lead to residues in food or feed, the need to set new or to amend existing maximum residue levels (MRLs) in accordance with Regulation (EC) No 470/2009 of the European Parliament and of the Council [2] or Regulation (EC) No 396/2005 of the European Parliament and of the Council [3] shall be verified, and any appropriate risk mitigation measures shall be taken to ensure that the applicable MRLs are not exceeded.
tlom za proizvode, ki se uporabljajo za razkuževanje vozil za prevoz živali;
surface water and sediment for products used in: (i) food, drink and milk industry sites; (ii) milking parlours; (iii) slaughterhouses and butcheries and (iv) large-scale catering kitchens and canteens;
mikroorganizmom v napravi za čiščenje odpadnih voda za proizvode, ki se uporabljajo za razkuževanje obutve in kopit živali;
soil for products used in: (i) food, drink and milk industry sites; (ii) slaughterhouses and butcheries; and (iii) large-scale catering kitchens and canteens.
za proizvode, ki lahko povzročajo ostanke v živilih ali krmi, se preveri, ali je treba določiti nove ali spremeniti obstoječe mejne vrednosti ostankov (MRL) v skladu z Uredbo (ES) št. 470/2009 Evropskega parlamenta in Sveta [2] ali Uredbo Evropskega parlamenta in Sveta (ES) št. 396/2005 [3], in sprejmejo vsi ustrezni ukrepi za zmanjšanje tveganja, da se veljavne MRL ne presežejo.
For products that may lead to residues in food or feed, the need to set new or to amend existing maximum residue levels (MRLs) in accordance with Regulation (EC) No 470/2009 or Regulation (EC) No 396/2005 shall be verified, and any appropriate risk mitigation measures shall be taken to ensure that the applicable MRLs are not exceeded.
površinski vodi in usedlinam za proizvode, ki se uporabljajo: i) na industrijskih območjih za predelavo živil, pijač in mleka; ii) v molziščih; iii) v klavnicah in mesnicah ter iv) velikih gostinskih kuhinjah in menzah;
Products shall not be incorporated in materials and articles intended to come into contact with food within the meaning of Article 1(1) of Regulation (EC) No 1935/2004, unless the Commission has established specific limits on the migration of amines, N-C10–16-alkyltrimethylenedi-, reaction products with chloroacetic acid into food or it has been established pursuant to that Regulation that such limits are not necessary.
tlom za proizvode, ki se uporabljajo na: i) industrijskih območjih za predelavo živil, pijač in mleka; ii) v klavnicah in mesnicah ter iii) velikih gostinskih kuhinjah in menzah;
The purity indicated in this column was the minimum degree of purity of the active substance used for the evaluation made in accordance with Article 89(1) of Regulation (EU) No 528/2012.
za proizvode, ki lahko povzročajo ostanke v živilih ali krmi, se preveri, ali bi bilo treba določiti nove ali spremeniti obstoječe mejne vrednosti ostankov (MRL) v skladu z Uredbo (ES) št. 470/2009 ali Uredbo (ES) št. 396/2005, in sprejmejo vsi ustrezni ukrepi za zmanjšanje tveganja, da se veljavne MRL ne presežejo;
The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.
proizvodi se ne vključijo v materiale in izdelke, namenjene za stik z živili v smislu člena 1(1) Uredbe (ES) št. 1935/2004, razen če je Komisija določila posebne mejne vrednosti za migracijo snovi amini, N-C10–16-alkiltrimetilendi-, reakcijski produkti s kloroocetno kislino v živila ali če je bilo v skladu z navedeno uredbo določeno, da takšne mejne vrednosti niso potrebne.
Regulation (EC) No 470/2009 of the European Parliament and of the Council of 6 May 2009 laying down Community procedures for the establishment of residue limits of pharmacologically active substances in foodstuffs of animal origin, repealing Council Regulation (EEC) No 2377/90 and amending Directive 2001/82/EC of the European Parliament and of the Council and Regulation (EC) No 726/2004 of the European Parliament and of the Council (OJ L 152, 16.6.2009, p. 11).
Čistost, navedena v tem stolpcu, je bila minimalna stopnja čistosti aktivne snovi, uporabljene za oceno v skladu s členom 89(1) Uredbe (EU) št. 528/2012.
Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residue levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EEC (OJ L 70, 16.3.2005, p. 1).
Čistost aktivne snovi v proizvodu, danem na trg, je lahko enaka ali drugačna, če je snov dokazano tehnično enakovredna aktivni snovi iz ocene.
Commission Implementing Regulation (EU) 2016/1084
Izvedbena uredba Komisije (EU) 2016/1084
approving biphenyl-2-ol as an existing active substance for use in biocidal products of product-type 3
o odobritvi bifenil-2-ola kot obstoječe aktivne snovi za uporabo v biocidnih proizvodih 3. vrste proizvodov
Biphenyl-2-ol has been evaluated for use in products of product-type 3, veterinary hygiene, as described in Annex V to Regulation (EU) No 528/2012.
Bifenil-2-ol je bil ocenjen za uporabo v proizvodih 3. vrste proizvodov, veterinarska higiena, kot je opisana v Prilogi V k Uredbi (EU) št. 528/2012.
Spain was designated as evaluating competent authority and submitted the assessment report together with its recommendations on 2 June 2014.
Španija, ki je bila imenovana za pristojni ocenjevalni organ, je 2. junija 2014 predložila poročilo o oceni, skupaj s svojimi priporočili.
In accordance with Article 7(2) of Delegated Regulation (EU) No 1062/2014, the opinion of the European Chemicals Agency was formulated on 8 December 2015 by the Biocidal Products Committee, having regard to the conclusions of the evaluating competent authority.
V skladu s členom 7(2) Delegirane uredbe (EU) št. 1062/2014 je Odbor za biocidne pripravke ob upoštevanju ugotovitev ocenjevalnega pristojnega organa 8. decembra 2015 oblikoval mnenje Evropske agencije za kemikalije.
According to that opinion, biocidal products of product-type 3 and containing biphenyl-2-ol may be expected to satisfy the criteria of Article 19(1)(b) of Regulation (EU) No 528/2012, provided that certain specifications and conditions concerning their use are complied with.
Iz navedenega mnenja je razvidno, da je za biocidne proizvode 3. vrste proizvodov, ki vsebujejo bifenil-2-ol, mogoče pričakovati, da izpolnjujejo merila iz člena 19(1)(b) Uredbe (EU) št. 528/2012, če so izpolnjeni nekatere specifikacije in pogoji glede njihove uporabe.
It is therefore appropriate to approve biphenyl-2-ol for use in biocidal products of product-type 3, subject to compliance with certain specifications and conditions.
Zato je primerno bifenil-2-ol odobriti za uporabo v biocidnih proizvodih 3. vrste proizvodov, pod pogojem da je ta v skladu z nekaterimi specifikacijami in pogoji.
A reasonable period should be allowed to elapse before an active substance is approved, in order to permit interested parties to take the preparatory measures necessary to meet the new requirements.
Pred odobritvijo aktivne snovi bi bilo treba zagotoviti ustrezno obdobje, da bi se zainteresiranim stranem omogočilo, da sprejmejo potrebne pripravljalne ukrepe za izpolnitev novih zahtev.
Biphenyl-2-ol is approved as an active substance for use in biocidal products of product-type 3, subject to the specifications and conditions set out in the Annex.
Bifenil-2-ol se odobri kot aktivna snov za uporabo v biocidnih proizvodih 3. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
EC No: 201-993-5
Št.
CAS No: 90-43-7
ES: 201-993-5
surface water, sediment and soil compartment.
zaradi ugotovljenih tveganj v zvezi z ocenjenimi uporabami se pri oceni proizvoda posebna pozornost nameni predvsem:
The purity indicated in this column was the minimum degree of purity of the active substance used for the evaluation made in accordance with Article 89(1) of Regulation (EU) No 528/2012.
površinski vodi, usedlinam in tlom;
The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.
za proizvode, ki lahko povzročajo ostanke v živilih ali krmi, se preveri, ali je treba določiti nove ali spremeniti obstoječe mejne vrednosti ostankov (MRL) v skladu z Uredbo (ES) št. 470/2009 Evropskega parlamenta in Sveta [2] ali Uredbo Evropskega parlamenta in Sveta (ES) št. 396/2005 [3], in sprejmejo vsi ustrezni ukrepi za zmanjšanje tveganja, da se veljavne mejne vrednosti ostankov ne presežejo.
Commission Implementing Regulation (EU) 2016/1085
Izvedbena uredba Komisije (EU) 2016/1085
approving Bacillus amyloliquefaciens strain ISB06 as an existing active substance for use in biocidal products of product-type 3
o odobritvi bakterije Bacillus amyloliquefaciens, sev ISB06, kot obstoječe aktivne snovi za uporabo v biocidnih proizvodih 3. vrste proizvodov
That list includes Bacillus subtilis.
Navedeni seznam vključuje bakterijo Bacillus subtilis.
As a result of the evaluation of the active substance originally notified, it became apparent that it belonged in fact to the species Bacillus amyloliquefaciens strain ISB06.
Na podlagi ocene prvotno priglašene aktivne snovi je postalo jasno, da aktivna snov dejansko spada v vrsto Bacillus amyloliquefaciens, sev ISB06.
The evaluation did not allow for conclusions to be drawn regarding any other substance complying with the definition of Bacillus subtilis in the abovementioned list of active substances in Delegated Regulation (EU) No 1062/2014.
Iz ocene ni mogoče sklepati o drugih snoveh, ki ustrezajo opredelitvi za bakterijo Bacillus subtilis, na zgoraj navedenem seznamu aktivnih snovi iz Delegirane uredbe (EU) št. 1062/2014.
Therefore, only Bacillus amyloliquefaciens strain ISB06 should be covered by this approval.
Zato bi bilo treba v tej odobritvi zajeti le bakterijo Bacillus amyloliquefaciens sev ISB06.
Bacillus amyloliquefaciens strain ISB06 has been evaluated for use in products of product-type 3, veterinary hygiene as described in Annex V to Regulation (EU) No 528/2012.
Opravljena je bila ocena bakterije Bacillus amyloliquefaciens, sev ISB06, za uporabo v 3. vrsti proizvodov (veterinarska higiena), kot je opredeljena v Prilogi V k Uredbi (EU) št. 528/2012.
Germany was designated as evaluating competent authority and submitted the assessment report together with its recommendations on 22 September 2014.
Nemčija, ki je bila imenovana za ocenjevalni pristojni organ, je 22. septembra 2014 predložila poročilo o oceni skupaj s svojimi priporočili.
According to that opinion, biocidal products of product-type 3 and containing Bacillus amyloliquefaciens strain ISB06 may be expected to satisfy the criteria of Article 19(1)(b) of Regulation (EU) No 528/2012, provided that certain specifications and conditions concerning their use are complied with.
Glede na navedeno mnenje je za biocidne proizvode 3. vrste proizvodov, ki vsebujejo bakterijo Bacillus amyloliquefaciens, sev ISB06, mogoče pričakovati, da izpolnjujejo merila iz člena 19(1)(b) Uredbe (EU) št. 528/2012, če so izpolnjeni nekatere specifikacije in pogoji za njihovo uporabo.
It is therefore appropriate to approve Bacillus amyloliquefaciens strain ISB06 for use in biocidal products of product-type 3, subject to compliance with certain specifications and conditions.
Zato je primerno bakterijo Bacillus amyloliquefaciens, sev ISB06, odobriti za uporabo v biocidnih proizvodih 3. vrste proizvodov, pod pogojem, da je ta v skladu z nekaterimi specifikacijami in pogoji.
Bacillus amyloliquefaciens strain ISB06 is approved as an active substance for use in biocidal products of product-type 3, subject to the conditions set out in the Annex.
Bakterija Bacillus amyloliquefaciens, sev ISB06, se odobri kot aktivna snov za uporabo v biocidnih proizvodih 3. vrste proizvodov, pri čemer se upoštevajo pogoji iz Priloge.
Bacillus amyloliquefaciens strain ISB06
Bacillus amyloliquefaciens, sev ISB06
1 January 2018
1. januar 2018
The authorisations of biocidal products are subject to the following conditions:
Dovoljenja za biocidne proizvode se izdajo pod naslednjima pogojema:
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance.
pri oceni proizvoda se posebna pozornost nameni vidikom izpostavljenosti, tveganja in učinkovitosti, povezanim s katero koli uporabo, zajeto v vlogi za izdajo dovoljenja, ki pa ni bila obravnavana v oceni tveganja aktivne snovi na ravni Unije;
In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to professional users.
zaradi ugotovljenih tveganj pri ocenjenih uporabah se pri oceni proizvoda posebna pozornost nameni poklicnim uporabnikom.
The purity indicated in this column was the minimum degree of purity of the active substance used for the evaluation made in accordance with Article 89(1) of Regulation (EU) No 528/2012.
Čistost, navedena v tem stolpcu, je bila minimalna stopnja čistosti aktivne snovi, uporabljene za oceno v skladu s členom 89(1) Uredbe (EU) št. 528/2012.
The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.
Čistost aktivne snovi v proizvodu, danem na trg, je lahko enaka ali drugačna, če je aktivna snov dokazano tehnično enakovredna aktivni snovi iz ocene.
Commission Implementing Regulation (EU) 2016/1086
Izvedbena uredba Komisije (EU) 2016/1086
approving 2-bromo-2-(bromomethyl)pentanedinitrile (DBDCB) as an existing active substance for use in biocidal products of product-type 6
o odobritvi 2-bromo-2-(bromometil)pentandinitrila (DBDCB) kot obstoječe aktivne snovi za uporabo v biocidnih proizvodih 6. vrste proizvodov
That list includes 2-bromo-2-(bromomethyl)pentanedinitrile (DBDCB).
Navedeni seznam vključuje 2-bromo-2-(bromometil)pentandinitril (DBDCB).
DBDCB has been evaluated in accordance with Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council [3] for use in product-type 6, in-can preservatives, as described in Annex V to that Directive, which corresponds to product-type 6 as described in Annex V to Regulation (EU) No 528/2012.
V skladu s členom 16(2) Direktive 98/8/ES Evropskega parlamenta in Sveta [3] je bila opravljena presoja DBDCB za uporabo v 6. vrsti proizvodov (sredstva za konzerviranje v vsebnikih), kot je opredeljena v Prilogi V k navedeni direktivi in ki ustreza 6. vrsti proizvodov, kot je opredeljena v Prilogi V k Uredbi (EU) št. 528/2012.
The Czech Republic was designated as evaluating competent authority and submitted the assessment reports together with its recommendations on 21 January 2009.
Češka, ki je bila imenovana za ocenjevalni pristojni organ, je 21. januarja 2009 predložila poročila o oceni skupaj s svojimi priporočili.
According to that opinion, biocidal products of product-type 6 and containing DBDCB may be expected to satisfy the requirements of Article 5 of Directive 98/8/EC, provided that certain specifications and conditions concerning their use are complied with.
Glede na navedeno mnenje je za biocidne proizvode 6. vrste proizvodov, ki vsebujejo DBDCB, mogoče pričakovati, da izpolnjujejo zahteve iz člena 5 Direktive 98/8/ES, če so izpolnjeni nekatere specifikacije in pogoji za njihovo uporabo.
It is therefore appropriate to approve DBDCB for use in biocidal products of product-type 6, subject to compliance with certain specifications and conditions.
Zato je primerno DBDCB odobriti za uporabo v biocidnih proizvodih 6. vrste proizvodov, pod pogojem, da je ta v skladu z nekaterimi specifikacijami in pogoji.
Since DBDCB meets the criteria for classification as skin sensitiser category 1 as defined in Annex I to Regulation (EC) No 1272/2008 of the European Parliament and of the Council [4], treated articles treated with or incorporating DBDCB should be labelled appropriately when placed on the market.
Ker DBDCB izpolnjuje merila za razvrstitev kot povzročitelj preobčutljivosti kože kategorije 1, kot je opredeljen v Prilogi I k Uredbi (ES) št. 1272/2008 Evropskega parlamenta in Sveta [4], bi bilo treba tretirane izdelke, ki so tretirani z njim ali ga vsebujejo, ustrezno označiti, ko se dajo na trg.
romo-2-(bromomethyl)pentanedinitrile (DBDCB) is approved as an active substance for use in biocidal products of product-type 6, subject to the specifications and conditions set out in the Annex.
romo-2-(bromometil)pentandinitril (DBDCB) se odobri kot aktivna snov za uporabo v biocidnih proizvodih 6. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
EC No: 252-681-0
Št.
CAS No: 35691-65-7
ES: 252-681-0
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance.
31. december 2027
In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to industrial and professional users.
Dovoljenja za biocidne proizvode se izdajo pod naslednjima pogojema:
The placing on the market of treated articles is subject to the following condition:
pri oceni proizvoda se posebna pozornost nameni vidikom izpostavljenosti, tveganja in učinkovitosti, povezanim s katero koli uporabo, zajeto v vlogi za izdajo dovoljenja, ki pa ni bila obravnavana v oceni tveganja aktivne snovi na ravni Unije;
The person responsible for the placing on the market of a treated article treated with or incorporating 2-bromo-2-(bromomethyl)pentanedinitrile (DBDCB) shall ensure that the label of that treated article provides the information listed in the second subparagraph of Article 58(3) of Regulation (EU) No 528/2012.
zaradi ugotovljenih tveganj pri ocenjenih uporabah se pri oceni proizvoda posebna pozornost nameni industrijskim in poklicnim uporabnikom.
The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.
oseba, ki je odgovorna za dajanje na trg tretiranega izdelka, ki je tretiran z 2-bromo-2-(bromometil)pentandinitrilom (DBDCB) ali ga vsebuje, zagotovi, da so na oznaki tega tretiranega izdelka navedene informacije iz drugega pododstavka člena 58(3) Uredbe (EU) št. 528/2012.
Commission Implementing Regulation (EU) 2016/1087
Izvedbena uredba Komisije (EU) 2016/1087
approving tolylfluanid as an existing active substance for use in biocidal products of product-type 7
o odobritvi tolilfluanida kot obstoječe aktivne snovi za uporabo v biocidnih proizvodih 7. vrste proizvodov
That list includes tolylfluanid.
Navedeni seznam vključuje tolilfluanid.
Tolylfluanid has been evaluated for use in products of product-type 7, film preservatives, as described in Annex V to Regulation (EU) No 528/2012.
Tolilfluanid je bil ocenjen za uporabo v 7. vrsti proizvodov (sredstva za zaščito (ohranitev) prevlek), kot je opredeljena v Prilogi V k Uredbi (EU) št. 528/2012.
Finland was designated as evaluating competent authority and submitted the assessment reports together with its recommendations on 17 March 2015.
Finska, ki je bila imenovana za ocenjevalni pristojni organ, je 17. marca 2015 predložila poročila o oceni skupaj s svojimi priporočili.
In accordance with Article 7(2) of Delegated Regulation (EU) No 1062/2014, the opinion of the European Chemicals Agency was formulated on 9 December 2015 by the Biocidal Products Committee, having regard to the conclusions of the evaluating competent authority.
V skladu s členom 7(2) Delegirane uredbe (EU) št. 1062/2014 je Odbor za biocidne pripravke ob upoštevanju ugotovitev ocenjevalnega pristojnega organa 9. decembra 2015 oblikoval mnenje Evropske agencije za kemikalije.
According to that opinion, biocidal products of product-type 7 and containing tolylfluanid may be expected to satisfy the criteria of Article 19(1)(b) of Regulation (EU) No 528/2012, provided that certain specifications and conditions concerning their use are complied with.
Glede na navedeno mnenje je za biocidne proizvode 7. vrste proizvodov, ki vsebujejo tolilfluanid, mogoče pričakovati, da izpolnjujejo merila iz člena 19(1)(b) Uredbe (EU) št. 528/2012, če so izpolnjeni nekatere specifikacije in pogoji za njihovo uporabo.
It is therefore appropriate to approve tolylfluanid for use in biocidal products of product-type 7, subject to compliance with certain specifications and conditions.
Zato je primerno tolilfluanid odobriti za uporabo v biocidnih proizvodih 7. vrste proizvodov, pod pogojem, da je ta v skladu z nekaterimi specifikacijami in pogoji.
Since tolylfluanid meets the criteria for classification as skin sensitiser category 1 as defined in Annex I to Regulation (EC) No 1272/2008 of the European Parliament and of the Council [3], treated articles treated with or incorporating tolylfluanid should be appropriately labelled when placed on the market.
Ker tolilfluanid izpolnjuje merila za razvrstitev kot povzročitelj preobčutljivosti kože kategorije 1, kot je opredeljen v Prilogi I k Uredbi (ES) št. 1272/2008 Evropskega parlamenta in Sveta [3], bi bilo treba tretirane izdelke, ki so tretirani z njim ali ga vsebujejo, ustrezno označiti, ko se dajo na trg.
Tolylfluanid is approved as an active substance for use in biocidal products of product-type 7, subject to the specifications and conditions set out in the Annex.
Tolilfluanid se odobri kot aktivna snov za uporabo v biocidnih proizvodih 7. vrste proizvodov, pri čemer se upoštevajo specifikacije in pogoji iz Priloge.
EC No: 211-986-9
Št.
CAS No: 731-27-1
EC: 211-986-9
96 % w/w
Št.
31 December 2027
96 mas. %
The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any use covered by an application for authorisation, but not addressed in the Union level risk assessment of the active substance.
31. december 2027
In view of the risks identified for the uses assessed, the product assessment shall pay particular attention to:
Dovoljenja za biocidne proizvode se izdajo pod naslednjima pogojema:
industrial or professional users;
pri oceni proizvoda se posebna pozornost nameni vidikom izpostavljenosti, tveganja in učinkovitosti, povezanim s katero koli uporabo, zajeto v vlogi za izdajo dovoljenja, ki pa ni bila obravnavana v oceni tveganja aktivne snovi na ravni Unije;
non-professional users of treated paints containing tolylfluanid as a film preservative;
zaradi ugotovljenih tveganj pri ocenjenih uporabah se pri oceni proizvoda posebna pozornost nameni:
surface water, soil and ground water, including the risk from degradation products.
industrijskim ali poklicnim uporabnikom;
The placing on the market of treated articles is subject to the following condition:
nepoklicnim uporabnikom tretiranih barv, ki vsebujejo tolilfluanid kot sredstvo za zaščito prevlek;
The person responsible for the placing on the market of a treated article treated with or incorporating tolylfluanid shall ensure that the label of that treated article provides the information listed in the second subparagraph of Article 58(3) of Regulation (EU) No 528/2012.
površinski vodi, tlom in podtalnici, vključno s tveganjem zaradi razgradnih produktov.
The active substance in the product placed on the market can be of equal or different purity if it has been proven technically equivalent with the evaluated active substance.
oseba, ki je odgovorna za dajanje na trg tretiranega izdelka, ki je tretiran s tolilfluanidom ali ga vsebuje, zagotovi, da so na oznaki tega tretiranega izdelka navedene informacije iz drugega pododstavka člena 58(3) Uredbe (EU) št. 528/2012.
Commission Implementing Regulation (EU) 2016/1088
Izvedbena uredba Komisije (EU) 2016/1088